DZ2652A1 - Dérivés d'acides benzazepinon-n-acétiques substitués par des acides phosphoniques leurs procédés de fabrication et médicaments contenant ces composés. - Google Patents

Dérivés d'acides benzazepinon-n-acétiques substitués par des acides phosphoniques leurs procédés de fabrication et médicaments contenant ces composés.

Info

Publication number
DZ2652A1
DZ2652A1 DZ980262A DZ980262A DZ2652A1 DZ 2652 A1 DZ2652 A1 DZ 2652A1 DZ 980262 A DZ980262 A DZ 980262A DZ 980262 A DZ980262 A DZ 980262A DZ 2652 A1 DZ2652 A1 DZ 2652A1
Authority
DZ
Algeria
Prior art keywords
benzazepinon
derivatives
compounds
manufacturing processes
medicaments containing
Prior art date
Application number
DZ980262A
Other languages
English (en)
French (fr)
Inventor
Harald Waldeck
Joerg Meil
Dirk Thormahlen
Michael Wurl
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Application granted granted Critical
Publication of DZ2652A1 publication Critical patent/DZ2652A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DZ980262A 1997-11-12 1998-11-11 Dérivés d'acides benzazepinon-n-acétiques substitués par des acides phosphoniques leurs procédés de fabrication et médicaments contenant ces composés. DZ2652A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19750002A DE19750002A1 (de) 1997-11-12 1997-11-12 Phosphonsäure-substituierte Benzazepinon-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
DZ2652A1 true DZ2652A1 (fr) 2003-03-15

Family

ID=7848410

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ980262A DZ2652A1 (fr) 1997-11-12 1998-11-11 Dérivés d'acides benzazepinon-n-acétiques substitués par des acides phosphoniques leurs procédés de fabrication et médicaments contenant ces composés.

Country Status (27)

Country Link
US (1) US5952327A (pl)
EP (1) EP0916679B1 (pl)
JP (1) JP4162780B2 (pl)
KR (1) KR19990045100A (pl)
CN (1) CN1187361C (pl)
AR (1) AR009911A1 (pl)
AT (1) ATE228144T1 (pl)
AU (1) AU746907B2 (pl)
BR (1) BR9804582A (pl)
CA (1) CA2253997C (pl)
CZ (1) CZ296123B6 (pl)
DE (2) DE19750002A1 (pl)
DK (1) DK0916679T3 (pl)
DZ (1) DZ2652A1 (pl)
ES (1) ES2186961T3 (pl)
HU (1) HU221177B1 (pl)
ID (1) ID21393A (pl)
IL (1) IL126984A (pl)
NO (1) NO317640B1 (pl)
NZ (1) NZ332744A (pl)
PL (1) PL191436B1 (pl)
PT (1) PT916679E (pl)
RU (1) RU2211219C2 (pl)
SK (1) SK283233B6 (pl)
TR (1) TR199802289A2 (pl)
UA (1) UA60304C2 (pl)
ZA (1) ZA9810316B (pl)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK14102003A3 (sk) * 2001-05-18 2004-08-03 Solvay Pharmaceuticals Gmbh Použitie zlúčenín s kombinovanou inhibičnou aktivitou k NEP/MP pri príprave liečiv
PT1438316E (pt) * 2001-10-19 2006-10-31 Ortho Mcneil Pharm Inc Compostos de acido fosfonico como inibidores de serina proteases
BR0306701A (pt) * 2002-01-16 2004-12-28 Solvay Pharm Bv Composto, sal do composto, sal de cálcio, método de preparação de um sal, composição farmacêutica, método de preparação de uma composição, e, uso de um sal
CL2004000544A1 (es) * 2003-03-18 2005-01-28 Pharmacia Corp Sa Organizada B Uso de una combinacion farmaceutica, de un antagonista del receptor de aldosterona y un inhibidor de endopeptidasa neutral, util para el tratamiento y prevencion de una condicion patologica relacionada con hipertension, disfuncion renal, insulinopati
US7427611B2 (en) * 2003-09-26 2008-09-23 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 1-(carboxyalkyl)-cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
US7452875B2 (en) 2003-09-26 2008-11-18 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
US7262184B2 (en) 2003-09-26 2007-08-28 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
SA04250283B1 (ar) * 2003-09-26 2008-05-26 سولفاي فارماسيتيكالز جي أم بي أتش مشتقات من amidomethy1-substituted1-(carboxyalkyl)-cyclopentylcarbonylamino-benzazepine-N-acetic acid
US7232813B2 (en) * 2004-01-12 2007-06-19 Solvay Pharmaceuticals B.V. Neutral endopeptidase (NEP) and human soluble endopeptidase (hSEP) inhibitors for prophylaxis and treatment of neuro-degenerative disorders
PL1706121T3 (pl) * 2004-01-12 2009-02-27 Turski Lechoslaw Inhibitory obojętnej endopeptydazy (NEP) i ludzkiej rozpuszczalnej endopeptydazy (HSEP) do zapobiegania i leczenia zaburzeń neurodegeneracyjnych
US20050267072A1 (en) * 2004-05-14 2005-12-01 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions containing dually acting inhibitors of neutral endopeptidase for the treatment of sexual dysfunction
US20050267124A1 (en) * 2004-05-14 2005-12-01 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous producing system and PDEV inhibiitors
EP1776095A1 (en) * 2004-06-23 2007-04-25 Solvay Pharmaceuticals GmbH Pharmaceutical compositions comprising nep-inhibitors, inhibitors of the endogenous endothelin producing system and at1-receptor antagonists
US20050288272A1 (en) * 2004-06-23 2005-12-29 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and AT1 receptor antagonists
WO2006064016A1 (en) 2004-12-15 2006-06-22 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising nep-inhibitors, inhibitors of the endogenous endothelin producing system and hmg coa reductase inhibitors
US20060205625A1 (en) * 2005-02-18 2006-09-14 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and diuretics
ATE464904T1 (de) * 2005-02-18 2010-05-15 Solvay Pharm Gmbh Pharmazeutische zusammensetzungen mit nep- inhibitoren, inhibitoren des endogenes endothelin produzierenden systems und diuretika
PL1968990T3 (pl) * 2005-12-27 2015-06-30 Otsuka Pharma Co Ltd Rozpuszczalny w wodzie związek benzoazepinowy i jego kompozycja farmaceutyczna
WO2007102171A2 (en) * 2006-03-07 2007-09-13 Panacea Biotec Ltd Novel salts of 1h-1-benzazepine-1-acetic acid, their preparation and pharmaceutical composition
US8198341B2 (en) 2008-12-18 2012-06-12 Icl-Ip America Inc. Method of making hydroxymethylphosphonate, polyurethane foam-forming compositions, polyurethane foam and articles made therefrom
US9441001B2 (en) 2012-10-17 2016-09-13 Icl-Ip America Inc. Method of making hydroxymethylphosphonate, polyurethane foam-forming compositions, polyurethane foam and articles made therefrom
US9528269B2 (en) 2014-06-09 2016-12-27 Johns Manville Roofing systems and roofing boards with non-halogenated fire retardant
US9815256B2 (en) 2014-06-09 2017-11-14 Johns Manville Foam boards including non-halogenated fire retardants
US9523195B2 (en) 2014-06-09 2016-12-20 Johns Manville Wall insulation boards with non-halogenated fire retardant and insulated wall systems
US9815966B2 (en) 2014-07-18 2017-11-14 Johns Manville Spray foams containing non-halogenated fire retardants
CN107383084A (zh) * 2017-06-14 2017-11-24 浙江嘉华化工有限公司 一种0‑乙基磷酸钠的制备方法
PL424453A1 (pl) 2018-01-31 2019-08-12 Forty-Four Pharmaceuticals Spółka Z Ograniczoną Odpowiedzialnością Sposoby zmniejszania szkodliwego działania niedoboru perfuzji narządów miąższowych przez inhibitory obojętnej endopeptydazy (NEP) i ludzkiej rozpuszczalnej endopeptydazy (hSEP)
PL424452A1 (pl) * 2018-01-31 2019-08-12 Forty-Four Pharmaceuticals Spółka Z Ograniczoną Odpowiedzialnością Inhibitory obojętnej endopeptydazy (NEP) i ludzkiej rozpuszczalnej endopeptydazy (hSEP) do profilaktyki i leczenia chorób oczu
CN115466754A (zh) * 2022-08-24 2022-12-13 中国人民解放军军事科学院防化研究院 一类P-手性α-羟(酯)基磷酸酯类化合物及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW198715B (pl) * 1991-04-19 1993-01-21 Dtsuka Seiyaku Kk
DE19510566A1 (de) * 1995-03-23 1996-09-26 Kali Chemie Pharma Gmbh Benzazepin-, Benzoxazepin- und Benzothiazepin-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US5877313A (en) * 1995-05-17 1999-03-02 Bristol-Myers Squibb Benzo-fused azepinone and piperidinone compounds useful in the inhibition of ACE and NEP
US5635504A (en) * 1995-06-07 1997-06-03 Bristol-Myers Squibb Co. Diazepine containing dual action inhibitors

Also Published As

Publication number Publication date
PL191436B1 (pl) 2006-05-31
EP0916679B1 (de) 2002-11-20
EP0916679A1 (de) 1999-05-19
IL126984A0 (en) 1999-09-22
HU221177B1 (en) 2002-08-28
JP4162780B2 (ja) 2008-10-08
BR9804582A (pt) 2000-05-09
NO985262D0 (no) 1998-11-11
DE59806345D1 (de) 2003-01-02
SK151698A3 (en) 1999-05-07
HUP9802517A3 (en) 2000-06-28
US5952327A (en) 1999-09-14
CN1187361C (zh) 2005-02-02
DE19750002A1 (de) 1999-05-20
AU746907B2 (en) 2002-05-02
AR009911A1 (es) 2000-05-03
DK0916679T3 (da) 2002-12-16
AU9234498A (en) 2000-06-08
NO985262L (no) 1999-05-14
RU2211219C2 (ru) 2003-08-27
HK1019338A1 (en) 2000-02-03
ZA9810316B (en) 1999-05-18
HUP9802517A2 (hu) 1999-09-28
CA2253997A1 (en) 1999-05-12
CZ356298A3 (cs) 1999-06-16
SK283233B6 (sk) 2003-04-01
TR199802289A3 (tr) 1999-06-21
IL126984A (en) 2001-07-24
CN1217334A (zh) 1999-05-26
ID21393A (id) 1999-06-03
PT916679E (pt) 2003-03-31
PL329635A1 (en) 1999-05-24
UA60304C2 (uk) 2003-10-15
CA2253997C (en) 2009-05-12
NO317640B1 (no) 2004-11-29
TR199802289A2 (xx) 1999-06-21
CZ296123B6 (cs) 2006-01-11
ATE228144T1 (de) 2002-12-15
JPH11292886A (ja) 1999-10-26
NZ332744A (en) 2000-06-23
ES2186961T3 (es) 2003-05-16
HU9802517D0 (en) 1998-12-28
KR19990045100A (ko) 1999-06-25

Similar Documents

Publication Publication Date Title
DZ2003A1 (fr) Dérivés de la benzazépine, de la benzoxazépine et de l'acide benzothiazépine-n-acétique ainsi que leurs procédés de preparation et médicaments contenant ces composés.
FR2714907B1 (fr) Nouveaux dérivés de l'Adénosine, leurs procédés de préparation, compositions pharmaceutiques les contenant.
DE69604714D1 (de) Stilbenderivate und diese enthaltende pharmazeutische Zusammensetzungen
DZ2614A1 (fr) Compositions pharmaceutiques topiques contenant des dérivés de résorcinol.
MY117896A (en) Quinazoline derivatives
NO963673L (no) Orale vehikkelblandinger
FR2703051B1 (fr) Nouvelles pyridothiadiazines, leurs procédés de préparation, et les compositions pharmaceutiques qui les contiennent.
DZ2653A1 (fr) Procédé de préparation de dérivés de la classe destaxoïdes.
ATE246180T1 (de) Benzofuranon-derivate und verfahren zu ihrer herstellung
FR2705673B1 (fr) Compositions comportant des dérivés d'acides aminés, leurs procédés de préparation et leurs utilisations.
OA09238A (fr) Dérivés d'isoindolinone, leurs procédés de préparation et les médicaments les contenant.
FR2687678B1 (fr) Nouveaux derives de l'adenosine, leurs procedes de preparation, compositions pharmaceutiques les contenant.
OA09209A (fr) "Dérivés de la thiéno-triazolo-diazépine, un procédé de préparation desdits composés et une composition thérapeutique les contenant".
FR2707638B1 (fr) Nouveaux dérivés d'amino-acides, leurs procédés de préparation et leur application thérapeutique.
FR2707085B1 (fr) Nouveaux dérivés d'alpha amino acides, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
ATE165822T1 (de) Chinolin-4-carbonylguanidin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
BG105862A (en) Light, extruded compositions containing a light, extrudable, ceramic carrier, methods for their use and preparartion
ATE115558T1 (de) Harnstoffderivate, deren herstellung sowie diese enthaltende pharmazeutische zusammensetzungen.
DE69917668D1 (de) Substanz gm-95, verfahren zu ihrer herstellung und ihre verwendung
FR2704547B1 (fr) Nouveaux composés pyrrolopyraziniques, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
DZ2721A1 (fr) Dérivés de 11-acétyl-12,13-dioxabicycloÄ8.2.11 tridecenone procédé pour leur préparation et médicaments contenant ces composés.
FR2659553B1 (fr) Procede de preparation de compositions homeopathiques a partir d'une solution initiale contenant une substance active.
OA09475A (fr) "Dérivés du (N-méthyl-N-alcoyl)amino-3 méthoxyméthylène-2 propane 1-o1, un procédé de préparation de ces mêmes composés et des compositions thérapeutiques les contenant".
ATE176242T1 (de) Uck14-verbindungen
DE69819002D1 (de) Polyhydroxyalkylpyrazine derivate,deren herstellung und diese enthaltende arzneimitteln